WPAHS will become a subsidiary of Highmark, which will assume approximately $1 billion in liabilities from the health system.
The potential acquisition may intensify the disagreements between Highmark and the University of Pittsburgh Medical Center, which ended contract negotiations with Highmark in early May due to the planned acquisition of WPAHS. The contract between the insurer and UPMC expires June 30, 2012.
WPAHS posted more than $48 million in operating losses during the first nine months of the 2011 fiscal year, which ends June 30, according to the report. Highmark reported a 146 percent increase in profits last year at $462.5 million.
The health system is expected to announce the arrangement with Highmark early this week.
Read the Pittsburgh Tribune-Review report on Highmark and West Penn Allegheny Health System.
Related Articles on West Penn Allegheny Health System:
Pittsburgh’s West Penn Allegheny, Highmark May Form New System with Cleveland Clinic
West Penn Allegheny Health Expected to Announce Plans for Medical School
Nine Physicians Sue Pittsburgh’s West Penn Allegheny for Alleged Cherry Picking
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
